ICUI ICU MED INC revenue, earnings and financials
For the quarter ended June 30, 2026, ICU MED INC reported revenue of $552M (up 0.5% from a year earlier), net income of $19.1M and diluted EPS of $0.76; over the last four quarters revenue was $2.16B and net income $30.1M; for the fiscal year ended December 2025 revenue was $2.23B, down 6.3% on the year before.
ICUI annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $2.23B, gross profit $822M, operating income $42.8M, net income $732K (margin 0.0%), EPS $0.03
- Fiscal year ended Dec 2024: revenue $2.38B, gross profit $825M, operating income $43.0M, net income −$118M (margin -4.9%), EPS −$4.83
- Fiscal year ended Dec 2023: revenue $2.26B, gross profit $740M, operating income $22.8M, net income −$29.7M (margin -1.3%), EPS −$1.23
- Fiscal year ended Dec 2022: revenue $2.28B, gross profit $698M, operating income −$42.9M, net income −$74.3M (margin -3.3%), EPS −$3.11
- Fiscal year ended Dec 2021: revenue $1.32B, gross profit $491M, operating income $123M, net income $103M (margin 7.8%), EPS $4.74
ICUI quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $552M (up 0.5% year over year), net income $19.1M, EPS $0.76
- Quarter ended Mar 31, 2026: revenue $530M (down 12.3% year over year), net income $30.1M, EPS $1.20
- Quarter ended Dec 31, 2025 (from the annual report): revenue $541M (down 14.1% year over year), net income −$15.7M, EPS −$0.63
- Quarter ended Sep 30, 2025: revenue $537M (down 8.9% year over year), net income −$3.40M, EPS −$0.14
- Quarter ended Jun 30, 2025: revenue $549M (down 8.0% year over year), net income $35.3M, EPS $1.43
- Quarter ended Mar 31, 2025: revenue $605M (up 6.7% year over year), net income −$15.5M, EPS −$0.63
- Quarter ended Dec 31, 2024 (from the annual report): revenue $630M (up 7.1% year over year), net income −$23.8M, EPS −$0.97
- Quarter ended Sep 30, 2024: revenue $589M (up 6.5% year over year), net income −$33.0M, EPS −$1.35
- Quarter ended Jun 30, 2024: revenue $596M (up 8.6% year over year), net income −$21.4M, EPS −$0.88
- Quarter ended Mar 31, 2024: revenue $567M (down 0.4% year over year), net income −$39.5M, EPS −$1.63
- Quarter ended Dec 31, 2023 (from the annual report): revenue $588M (up 1.7% year over year), net income −$17.1M, EPS −$0.71
- Quarter ended Sep 30, 2023: revenue $553M (down 7.5% year over year), net income $7.24M, EPS $0.30
- Quarter ended Jun 30, 2023: revenue $549M (down 2.1% year over year), net income −$9.93M, EPS −$0.41
- Quarter ended Mar 31, 2023: revenue $569M (up 4.7% year over year), net income −$9.81M, EPS −$0.41
- Quarter ended Dec 31, 2022 (from the annual report): revenue $578M (up 69.7% year over year), net income −$18.9M, EPS −$0.64
- Quarter ended Sep 30, 2022: revenue $598M (up 77.9% year over year), net income −$9.81M, EPS −$0.55
- Quarter ended Jun 30, 2022: revenue $561M (up 74.4% year over year), net income −$7.47M, EPS −$0.31
- Quarter ended Mar 31, 2022: revenue $543M (up 70.8% year over year), net income −$38.1M, EPS −$1.61
- Quarter ended Dec 31, 2021 (from the annual report): revenue $341M, net income $19.9M, EPS $0.91
- Quarter ended Sep 30, 2021: revenue $336M, net income $31.1M, EPS $1.43
ICUI cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $180M, share buybacks $8.77M
- Fiscal year ended Dec 2024: operating cash flow $204M, share buybacks $12.0M
- Fiscal year ended Dec 2023: operating cash flow $166M, share buybacks $9.35M
- Fiscal year ended Dec 2022: operating cash flow −$62.1M, share buybacks $10.9M
- Fiscal year ended Dec 2021: operating cash flow $268M, share buybacks $8.34M
ICUI balance sheet
- Jun 30, 2026: cash n/a, total assets $3.97B, total liabilities n/a, shareholders' equity $2.15B, long-term debt $1.21B
- Mar 31, 2026: cash n/a, total assets $4.01B, total liabilities n/a, shareholders' equity $2.11B, long-term debt $1.26B
- Dec 31, 2025: cash n/a, total assets $4.05B, total liabilities n/a, shareholders' equity $2.12B, long-term debt $1.27B
- Sep 30, 2025: cash n/a, total assets $4.10B, total liabilities n/a, shareholders' equity $2.13B, long-term debt $1.31B
- Jun 30, 2025: cash n/a, total assets $4.11B, total liabilities n/a, shareholders' equity $2.12B, long-term debt $1.34B
- Mar 31, 2025: cash n/a, total assets $4.18B, total liabilities n/a, shareholders' equity $1.99B, long-term debt $1.49B
- Dec 31, 2024: cash n/a, total assets $4.20B, total liabilities n/a, shareholders' equity $1.97B, long-term debt $1.53B
- Sep 30, 2024: cash n/a, total assets $4.31B, total liabilities n/a, shareholders' equity $2.05B, long-term debt $1.54B
What is ICUI's revenue?
ICU MED INC reported $2.16B of revenue over its last four quarters, through June 30, 2026.
Is ICUI profitable?
Yes. ICU MED INC earned $30.1M over the last four quarters.
What is ICUI's EPS?
Diluted earnings per share over the last four quarters were $1.19; $0.76 in the latest quarter.